At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
oral protein nutritional supplement (Fresubin protein powder) +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Impact of Predialytic Oral Protein-based Supplements on Nutritional Status and Quality of Life in Hemodialysis Patients
In Brief
A clinical study evaluating oral protein nutritional supplement (Fresubin protein powder) and routine nutrition regimen for Hemodialysis Complication. Completed, enrolled 100 participants across 1 site.
Detailed Summary
The aim of this work is to study the effects of oral protein-based supplements on nutritional status in hemodialysis patients
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemodialysis Complication
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedJul 2023
Enrollment StartAug 2023
Primary CompletionJun 2024
Study CompletionJul 2024
TodayJul 2026
First PostedJul 19, 2023
Enrollment StartAug 1, 2023
Primary CompletionJun 15, 2024
Study CompletionJul 1, 2024
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 3.0 years ago
Interventions
oral protein nutritional supplement (Fresubin protein powder)dietary
50 patients will receive oral protein nutritional supplement (Fresubin protein powder 25mg/5scoops per hemodialysis session) 1 hour before the start of the session (predialytic) for 3 months
routine nutrition regimenother
50 patients will receive a routine nutrition regimen for 3 months. (control group)